OUR SAVINGS AND SUPPORT PROGRAM
We want to ensure that patients using our innovative therapies get the support and savings they need to stay on treatment.
OUR PIPELINE
Our pipeline currently includes several investigational product candidates at various stages of development.
OUR TECHNOLOGIES
Neurelis has a proprietary technology portfolio that includes Intravail®, ProTek®, and Hydrogel™ for drug delivery enhancement. These three non-invasive drug delivery and stabilization technologies are applicable to a wide range of molecules, including therapeutic proteins, peptides, and non-peptide large and small molecules. Our technologies offer exceptional potential value in enhancing drug development and clinical performance.
ABOUT NEURELIS
Neurelis is a neuroscience-based company dedicated to enhancing therapeutic benefit and addressing unmet needs in patient care.
KEEP CURRENT
Get the most up-to-date information about Neurelis and our products.